S
Sheryl L. Windsor
Researcher at University of Kansas
Publications - 21
Citations - 2113
Sheryl L. Windsor is an academic researcher from University of Kansas. The author has contributed to research in topics: Eicosapentaenoic acid & Cholesterol. The author has an hindex of 14, co-authored 17 publications receiving 1730 citations. Previous affiliations of Sheryl L. Windsor include University of Bonn & University of Missouri–Kansas City.
Papers
More filters
Journal ArticleDOI
Safety and Efficacy of Omacor in Severe Hypertriglyceridemia
William S. Harris,Henry N. Ginsberg,Narin Arunakul,Neil S. Shachter,Sheryl L. Windsor,Marian Adams,Lars Berglund,Karin Osmundsen +7 more
TL;DR: The availability of a potent and safe omega-3 fatty acid preparation for this patient population should diminish the risk for acute pancreatitis, and may also reduce the long-term risk for cardiovascular disease.
Journal ArticleDOI
Omega-3 Fatty Acids in Cardiac Biopsies From Heart Transplantation Patients Correlation With Erythrocytes and Response to Supplementation
William S. Harris,Scott A. Sands,Sheryl L. Windsor,Hakim Azfar Ali,Tracy L. Stevens,Anthony Magalski,Charles B. Porter,A. Michael Borkon +7 more
TL;DR: RBC EPA-DHA was highly correlated with cardiac EPA+DHA; the RBC omega-3 response to supplementation was similar to that of the heart; RBCs are easily collected and analyzed and they have a less variable FA composition than plasma.
Journal ArticleDOI
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Michael E. Nassif,Sheryl L. Windsor,Barry A. Borlaug,Dalane W. Kitzman,Sanjiv J. Shah,Fengming Tang,Yevgeniy Khariton,Ali O. Malik,Taiyeb M. Khumri,Guillermo E. Umpierrez,Sumant Lamba,Kavita Sharma,Sadiya S. Khan,Lokesh Chandra,Robert Gordon,John J. Ryan,Sunit-Preet Chaudhry,Susan M Joseph,Chen H Chow,Manreet Kanwar,Michael Pursley,Elias S. Siraj,Gregory D. Lewis,Barry S Clemson,Michael Fong,Mikhail Kosiborod +25 more
TL;DR: In this paper, the authors evaluated whether the SGLT2 inhibitor dapagliflozin improves the primary endpoint of KCCQ-CS, a measure of heart failure-related health status, at 12 weeks after treatment initiation.
Journal ArticleDOI
Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases
William S. Harris,Gouping Lu,Gro S. Rambjør,Ann I. Wålen,Joseph A. Ontko,Q. Cheng,Sheryl L. Windsor +6 more
TL;DR: The data suggest that endogenous lipase activities may be altered by nutritional interventions, and further, that accelerated lipolysis could contribute, at least in part, to the observed effects of n-3 fatty acids on human lipoprotein metabolism.
Journal ArticleDOI
Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans
TL;DR: It is concluded that EPA appears to be primarily responsible for TG-lowering (and LDL-C raising) effects of fish oil.